CClinicalTrials.gg
Status unknownNCT02718989Updated May 30, 2017

Modulation of H-reflex After Application of Electric Currents in Healthy People

An interventional study of Transcutaneous Electrical Stimulation and 10Kilohertz (KHz) in Spasticity, sponsored by University of Castilla-La Mancha. Status unknown at 1 site in Spain. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-05-30.

Sponsored by University of Castilla-La Mancha · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified May 2017), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

The purpose of this study is to determinate whether the application of electric currents produce changes in the excitability of alpha moto neurone. Moreover evidence whether the effect of the electric currents can change the tone of the muscle under stimulation in healthy volunteers

Read the detailed description

In the last years several experimental studies have evidenced that the transcutaneous electric nerve stimulation (TENS) in peripheric application can cause a decrease of spasticity and modulation of H-reflexes.

But if the application is in the central nervous system the results are different. So the purpose of this study is quantify the modulation of the excitability of alpha moto neurone when the application of the current is in the central nervous system compared with a sham group.

02

Conditions studied

  • Spasticity

Browse trials for

Keywords

  • H-reflex
  • TENS
  • Tone
03

In context

Muscle Spasticity

704 studies on the registry are indexed under Muscle Spasticity; 149 are open to participants now.

This study's planned enrollment of 30 is below the median of 36 across 525 interventional studies indexed under Muscle Spasticity.

Browse Muscle Spasticity studies →

Lead sponsor

University of Castilla-La Mancha is the lead sponsor of 104 studies on the registry; 24 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Participants will be volunteer healthy students of Physiotherapy, University of Castilla - La Mancha, older than 18 years.

Exclusion criteria

Exclusion Criteria:

  • Neuromuscular disease
  • Epilepsy
  • Trauma, surgery or pain affecting the upper limb, shoulder girdle or cervical area
  • Osteosynthesis material in the upper limb
  • Diabetes
  • Cancer
  • Cardiovascular disease
  • Pacemaker or other implanted electrical device
  • Take any drug (NSAIDs, corticosteroids, antidepressants, analgesics, antiepileptics, ...) during the study and in the previous 7 days.
  • Presence of tattoos or other external agent introduced into the treatment or assessment area.
  • Pregnancy
  • Sensitivity disturbance in lower limb
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    10 Kilohertz (KHz)

    Transcutaneous application of 10 Kilohertz (KHz) current over the back for a 40 minutes session. The intensity of the current will increase until participants report a "strong but comfortable" sensation, just below motor threshold.

    Device: Transcutaneous Electrical Stimulation · Device: 10Kilohertz (KHz)

  • Experimental
    Transcutaneous Electrical Stimulation

    Transcutaneous application of TENS current over the back for a 40 minutes session. The intensity of the current will increase until participants report a "strong but comfortable" sensation, just below motor threshold. Currents parameters are frequency 100 Hz and pulse width 100 microseconds

    Device: Transcutaneous Electrical Stimulation

  • Sham comparator
    Sham stimulation

    Electrodes are placed over the back for a 40 minutes in the same manner as experimental groups, but will be applied a sham electrical stimulation increasing the current intensity of an unconnected channel.

    Device: Sham stimulation

Interventions

  • DeviceTranscutaneous Electrical Stimulation

    TENS transcutaneous electrical stimulation over the back the electrotherapy device Myomed 932. (Enraf-Nonius, Delft, Netherlands)

    Also known as: TENS

  • Device10Kilohertz (KHz)

    10 KHz transcutaneous electrical stimulation over back through the electrotherapy device Myomed 932. (Enraf-Nonius, Delft, Netherlands)

  • DeviceSham stimulation

    Sham transcutaneous electrical stimulation over back through the electrotherapy device Myomed 932. (Enraf-Nonius, Delft, Netherlands)

06

What researchers measure

Primary outcomes

  1. Baseline H reflex

    H-reflex data are obtained by EMG signal. The EMG electrode (SignalConditioningElectrodes v2.3, Delsys Inc., USA) is fixed on triceps surae by the SENIAM protocol (www.seniam.org). The stimulator electrode is fixed on the peroneus nerve, in the popliteal fossa.

    Time frame: baseline at 0 min.

  2. During treatment H reflex

    H-reflex data are obtained by EMG signal. The EMG electrode (SignalConditioningElectrodes v2.3, Delsys Inc., USA) is fixed on triceps surae by the SENIAM protocol (www.seniam.org). The stimulator electrode is fixed on the peroneus nerve, in the popliteal fossa.

    Time frame: During treatment at 33min.

  3. Post treatment H reflex

    H-reflex data are obtained by EMG signal. The EMG electrode (SignalConditioningElectrodes v2.3, Delsys Inc., USA) is fixed on triceps surae by the SENIAM protocol (www.seniam.org). The stimulator electrode is fixed on the peroneus nerve, in the popliteal fossa.

    Time frame: Immediately after treatment at 40 min.

Secondary outcomes

  1. Baseline muscle tone

    This outcome measure is obtained by a device named MyotonPro. It is a commercial device made to calculate myotonometrics properties of the muscle. It is a non-invasive method to calculate the muscle tone. The investigators obtained many parameters like muscle stiffness, frequency and decrement.

    Time frame: Baseline at 0 min.

  2. Muscle tone during treatment

    This outcome measure is obtained by a device named MyotonPro. It is a commercial device made to calculate myotonometrics properties of the muscle. It is a non-invasive method to calculate the muscle tone. The investigators obtained many parameters like muscle stiffness, frequency and decrement.

    Time frame: During treatment at 35 min.

  3. Muscle tone post-treatment

    This outcome measure is obtained by a device named MyotonPro. It is a commercial device made to calculate myotonometrics properties of the muscle. It is a non-invasive method to calculate the muscle tone. The investigators obtained many parameters like muscle stiffness, frequency and decrement.

    Time frame: Post-treatment at 42min

07

Study locations

1 site
  • Diego Serrano-Muñoz
    Talavera de la reina, Castilla-La Mancha 45600, Spain
08

References and documents

Individual participant data

Plan to share: Yes

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 30, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02718989
Lead sponsor
University of Castilla-La Mancha
Responsible party
Sponsor
First posted
Mar 24, 2016
Start date
Jun 2017 (estimated)
Primary completion
Aug 2017 (estimated)
Completion
Oct 2017 (estimated)
Last update
May 30, 2017

Study contacts

Diego Serrano-Muñoz, MsC
Contact
dserrarno@sescam.jccm.es
0034 925247700 ext. 783
Julio Gómez-Soriano, PhD
Contact
julio.soriano@uclm.es
0034 925268800 ext. 5845
Diego Serrano-Muñoz, MsC
principal investigator · Hospital Nacional de Parapléjicos de Toledo

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion